1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Assessing Risks of Glaucoma
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2021
-
Mark
The future is old – Patients with topical ocular hypotensive treatment in the Nordic region between 2008 and 2017 with projections for 2040
(
- Contribution to journal › Article
- 2013
-
Mark
Neuroprotective effects of topical CB1 agonist WIN 55212-2 on retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat
(
- Contribution to journal › Article
- 2005
-
Mark
Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension.
(
- Contribution to journal › Article
- 2001
-
Mark
Lack of long-term drift in timolol's effectiveness in patients with ocular hypertension
(
- Contribution to journal › Article
- 2000
-
Mark
Long-term effects of timolol therapy in ocular hypertension : a double-masked, randomised trial
(
- Contribution to journal › Article
-
Mark
Glaucoma follow-up when converting from long to short perimetric threshold tests
(
- Contribution to journal › Article
-
Mark
Reliability of computerized perimetric threshold tests as assessed by reliability indices and threshold reproducibility in patients with suspect and manifest glaucoma
(
- Contribution to journal › Article
- 1998
-
Mark
Costs of treating primary open-angle glaucoma and ocular hypertension : A retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States
(
- Contribution to journal › Article
-
Mark
Evaluation of a new perimetric threshold strategy, SITA, in patients with manifest and suspect glaucoma
(
- Contribution to journal › Article